Prioritizing genes responsible for host resistance to influenza using network approaches

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Bao, Suying ^a   Zhou, Xueya ^b   Zhang, Liangcai ^c   Zhou, Jie ^a   To, Kelvin Kai Wang ^a   Wang, Binbin ^d   Wang, Liqiu ^a,e   Zhang, Xuegong ^b   Song, You Qiang ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TSINGHUA UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

^d NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^e DEPARTMENT OF INDUSTRIAL AND MANUFACTURING SYSTEMS ENGINEERING   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HOST RESISTANCE; HOST RESISTANCE GENE; HUMAN; INFLUENZA; MOUSE STRAIN; NONHUMAN; QUANTITATIVE TRAIT LOCUS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SURVIVAL;

MAMMALIA; MUS; ORTHOMYXOVIRIDAE;

ANIMALS; DISEASE RESISTANCE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA, HUMAN; MICE; ORTHOMYXOVIRIDAE; QUANTITATIVE TRAIT LOCI; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887878520     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-816     Document Type: Article

References (68)

1. Casanova JL, Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 2004, 4(1):55-66. 10.1038/nri1264, 14704768.
2. Hill AV. Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 2006, 40:469-486. 10.1146/annurev.genet.40.110405.090546, 17094741.
3. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988, 318(12):727-732. 10.1056/NEJM198803243181202, 3347221.
4. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330(6010):1551-1557. 3235490, 21051598.
5. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, et al. Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: a Genome-Wide Association Study. Gastroenterology 2010, 138(4):1338-U1173. 10.1053/j.gastro.2009.12.056, 20060832.
6. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317(5844):1522-1527. 10.1126/science.1139522, 17872438.
7. Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, De Smet F, Tranchevent LC, De Moor B, Marynen P, Hassan B, et al. Gene prioritization through genomic data fusion. Nat Biotechnol 2006, 24(5):537-544. 10.1038/nbt1203, 16680138.
8. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008, 197(1):18-24. 10.1086/524064, 18171280.
9. Srivastava B, Blazejewska P, Hessmann M, Bruder D, Geffers R, Mauel S, Gruber AD, Schughart K. Host genetic background strongly influences the response to influenza a virus infections. PloS one 2009, 4(3):e4857. 10.1371/journal.pone.0004857, 2654507, 19293935.
10. Boon AC, deBeauchamp J, Hollmann A, Luke J, Kotb M, Rowe S, Finkelstein D, Neale G, Lu L, Williams RW, et al. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 2009, 83(20):10417-10426. 10.1128/JVI.00514-09, 2753106, 19706712.
11. Kim JH, Hatta M, Watanabe S, Neumann G, Watanabe T, Kawaoka Y. Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in mice. J Gen Virol 2010, 91(Pt 5):1284-1289. 2878586,2878586, 20016035.
12. Aditama TY, Samaan G, Kusriastuti R, Purba WH, Misriyah, Santoso H, Bratasena A, Maruf A, Sariwati E, Setiawaty V, et al. Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin Infect Dis 2011, 53(12):1237-1244. 10.1093/cid/cir740, 22016499.
13. Toth LA, Williams RW. A quantitative genetic analysis of slow-wave sleep in influenza-infected CXB recombinant inbred mice. Behav Genet 1999, 29(5):339-348. 10.1023/A:1021661901196, 10765562.
14. Boivin GA, Pothlichet J, Skamene E, Brown EG, Loredo-Osti JC, Sladek R, Vidal SM. Mapping of clinical and expression quantitative trait loci in a sex-dependent effect of host susceptibility to mouse-adapted influenza H3N2/HK/1/68. J Immunol 2012, 188(8):3949-3960. 10.4049/jimmunol.1103320, 22427645.
15. Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu L, Hessman M, Alberts R, Williams RW, Schughart K. Distinct gene loci control the host response to influenza H1N1 virus infection in a time-dependent manner. BMC genomics 2012, 13:411. 10.1186/1471-2164-13-411, 3479429, 22905720.
16. Ferris MT, Aylor DL, Bottomly D, Whitmore AC, Aicher LD, Bell TA, Bradel-Tretheway B, Bryan JT, Buus RJ, Gralinski LE, et al. Modeling host genetic regulation of influenza pathogenesis in the collaborative cross. PLoS pathogens 2013, 9(2):e1003196. 10.1371/journal.ppat.1003196, 3585141, 23468633.
17. Kohler S, Bauer S, Horn D, Robinson PN. Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 2008, 82(4):949-958. 10.1016/j.ajhg.2008.02.013, 2427257, 18371930.
18. Nitsch D, Tranchevent LC, Thienpont B, Thorrez L, Van Esch H, Devriendt K, Moreau Y. Network analysis of differential expression for the identification of disease-causing genes. PloS one 2009, 4(5):e5526. 10.1371/journal.pone.0005526, 2677677, 19436755.
19. Nitsch D, Goncalves JP, Ojeda F, de Moor B, Moreau Y. Candidate gene prioritization by network analysis of differential expression using machine learning approaches. BMC bioinformatics 2010, 11:460. 10.1186/1471-2105-11-460, 2945940, 20840752.
20. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, et al. Database issue STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013, 41:D808-815. Database issue.
21. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39(4):561-577.
22. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol 1988, 8(10):4518-4523. 365527, 2903437.
23. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 2006, 7(5):517-523. 10.1038/ni1322, 16565719.
24. Keynan Y, Juno J, Meyers A, Ball TB, Kumar A, Rubinstein E, Fowke KR. Chemokine Receptor 5 Delta 32 Allele in Patients with Severe Pandemic (H1N1) 2009. Emerg Infect Dis 2010, 16(10):1621-1622. 10.3201/eid1610.100108, 3294998, 20875295.
25. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30(4):556-565. 10.1016/j.immuni.2009.02.005, 2803103, 19362020.
26. Verma D, Lerm M, Blomgran Julinder R, Eriksson P, Soderkvist P, Sarndahl E. Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases?. Arthritis Rheum 2008, 58(3):888-894. 10.1002/art.23286, 18311798.
27. Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J Virol 2002, 76(2):582-590. 10.1128/JVI.76.2.582-590.2002, 136822, 11752149.
28. Zuniga J, Buendia-Roldan I, Zhao Y, Jimenez L, Torres D, Romo J, Ramirez G, Cruz A, Vargas-Alarcon G, Sheu CC, et al. Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J 2012, 39(3):604-610. 10.1183/09031936.00020611, 3816497, 21737555.
29. Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P. Protective role of beta interferon in host defense against influenza A virus. J Virol 2007, 81(4):2025-2030. 10.1128/JVI.01718-06, 1797552, 17151098.
30. Tang YW, Li H, Wu H, Shyr Y, Edwards KM. Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine. J Infect Dis 2007, 196(7):1021-1025. 10.1086/521370, 17763324.
31. La D, Czarnecki C, El-Gabalawy H, Kumar A, Meyers AF, Bastien N, Simonsen JN, Plummer FA, Luo M. Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study. PloS one 2011, 6(12):e29200. 10.1371/journal.pone.0029200, 3247251, 22216211.
32. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012, 484(7395):519-523. 10.1038/nature10921, 3648786, 22446628.
33. Bottomly D, Ferris MT, Aicher LD, Rosenzweig E, Whitmore A, Aylor DL, Haagmans BL, Gralinski LE, Bradel-Tretheway BG, Bryan JT, et al. Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice. G3 (Bethesda) 2012, 2(2):213-221. 2012, 3284329, 22384400.
34. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011, 27(3):431-432. 10.1093/bioinformatics/btq675, 3031041, 21149340.
35. Narwaney KJ, Glanz JM, Norris JM, Fingerlin TE, Hokanson JE, Rewers M, Hambidge SJ. Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children. Vaccine 2013, 31(7):1123-1128. 10.1016/j.vaccine.2012.12.026, 23261040.
36. Morales-Garcia G, Falfan-Valencia R, Garcia-Ramirez RA, Camarena A, Ramirez-Venegas A, Castillejos-Lopez M, Perez-Rodriguez M, Gonzalez-Bonilla C, Grajales-Muniz C, Borja-Aburto V, et al. Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study. BMC Infect Dis 2012, 12:299. 10.1186/1471-2334-12-299, 3534505, 23148654.
37. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994, 1(7):533-541. 10.1016/1074-7613(94)90043-4, 7600282.
38. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR, Barber GN. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 2000, 13(1):129-141. 10.1016/S1074-7613(00)00014-5, 10933401.
39. Tuite A, Elias M, Picard S, Mullick A, Gros P. Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6 J mice. Genes Immun 2005, 6(8):672-682.
40. Hicks JT, Ennis FA, Kim E, Verbonitz M. The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. J Immunol 1978, 121(4):1437-1445.
41. Poland GA, Ovsyannikova IG, Jacobson RM. Immunogenetics of seasonal influenza vaccine response. Vaccine 2008, 26(Suppl 4):D35-D40. 2610683, 19230157.
42. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, Ahlquist P, Kawaoka Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454(7206):890-893. 10.1038/nature07151, 2574945, 18615016.
43. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139(7):1243-1254. 10.1016/j.cell.2009.12.017, 2824905, 20064371.
44. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, et al. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139(7):1255-1267. 10.1016/j.cell.2009.12.018, 2892837, 20064372.
45. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, et al. Human host factors required for influenza virus replication. Nature 2010, 463(7282):813-817. 10.1038/nature08699, 2862546, 20027183.
46. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S, et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463(7282):818-822. 10.1038/nature08760, 20081832.
47. Ding M, Lu L, Toth LA. Gene expression in lung and basal forebrain during influenza infection in mice. Genes Brain Behav 2008, 7(2):173-183. 10.1111/j.1601-183X.2007.00335.x, 17696998.
48. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF, Palese P, Taubenberger JK, Garcia-Sastre A, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006, 443(7111):578-581. 2615558, 17006449.
49. Alberts R, Srivastava B, Wu H, Viegas N, Geffers R, Klawonn F, Novoselova N, do Valle TZ, Panthier JJ, Schughart K. Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection. Microbes Infect 2010, 12(4):309-318. 10.1016/j.micinf.2010.01.008, 20114087.
50. Onishi M, Morimoto S, Yang J, Okaishi K, Katsuya T, Shimizu M, Okuro M, Sakurai S, Onishi T, Ogihara T. Association of angiotensin-I converting enzyme DD genotype with influenza pneumonia in the elderly. Geriatr Gerontol Int 2003, 2:8-15.
51. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, et al. Differential roles of MDA5 and RIG- helicases in the recognition of RNA viruses. Nature 2006, 441(7089):101-105. 10.1038/nature04734, 16625202.
52. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 2006, 103(22):8459-8464. 10.1073/pnas.0603082103, 1464000, 16714379.
53. Mulcahy H, O'Rourke KP, Adams C, Molloy MG, O'Gara F. LST1 and NCR3 expression in autoimmune inflammation and in response to IFN-gamma, LPS and microbial infection. Immunogenetics 2006, 57(12):893-903. 10.1007/s00251-005-0057-2, 16362817.
54. Halder UC, Bhowmick R, Roy Mukherjee T, Nayak MK, Chawla-Sarkar M. Phosphorylation Drives an Apoptotic Protein to Activate Antiapoptotic Genes: paradigm of influenza a matrix 1 protein function. J Biol Chem 2013, 288(20):14554-14568. 10.1074/jbc.M112.447086, 23548901.
55. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
56. Chapman SJ, Khor CC, Vannberg FO, Frodsham A, Walley A, Maskell NA, Davies CW, Segal S, Moore CE, Gillespie SH, et al. IkappaB genetic polymorphisms and invasive pneumococcal disease. Am J Respir Crit Care Med 2007, 176(2):181-187. 10.1164/rccm.200702-169OC, 17463416.
57. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM, Schaffner W, Craig AS, Griffin MR. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 2005, 118(3):285-291. 10.1016/j.amjmed.2004.09.016, 15745727.
58. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 2002, 8(9):950-954. 10.1038/nm757, 12195436.
59. Hussell T, Pennycook A, Openshaw PJ. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol 2001, 31(9):2566-2573. 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L, 11536154.
60. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 2007, 104(30):12479-12481. 10.1073/pnas.0705289104, 1924467, 17640882.
61. Perrone LA, Szretter KJ, Katz JM, Mizgerd JP, Tumpey TM. Mice Lacking Both TNF and IL-1 Receptors Exhibit Reduced Lung Inflammation and Delay in Onset of Death following Infection with a Highly Virulent H5N1 Virus. J Infect Dis 2010, 202(8):1161-1170. 10.1086/656365, 2941567, 20815704.
62. Shale M, Czub M, Kaplan GG, Panaccione R, Ghosh S. Anti-tumor necrosis factor therapy and influenza: keeping it in perspective. Ther Adv Gastroenterol 2010, 3(3):173-177.
63. Faustman D, Davis M. TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov 2010, 9(6):482-493. 10.1038/nrd3030, 20489699.
64. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003, 3(9):745-756. 10.1038/nri1184, 12949498.
65. Kuchipudi SV, Dunham SP, Nelli R, White GA, Coward VJ, Slomka MJ, Brown IH, Chang KC. Rapid death of duck cells infected with influenza: a potential mechanism for host resistance to H5N1. Immunol Cell Biol 2012, 90(1):116-123. 10.1038/icb.2011.17, 3257048, 21423263.
66. Kodama S, Davis M, Faustman DL. The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. Cell Mol Life Sci 2005, 62(16):1850-1862. 10.1007/s00018-005-5022-6, 15968469.
67. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, Fitzgerald S, et al. Database issue Ensembl 2012. Nucleic Acids Res 2012, 40:D84-D90. 10.1093/nar/gkr991, 3245178, 22086963, Database issue.
68. Stertz S, Shaw ML. Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes Infect 2011, 13(5):516-525. 10.1016/j.micinf.2011.01.012, 3071880, 21276872.